Home › NDC Lookup › Ingredients › Sennosides And Docusate Sodium › 68788-8780-01
SENNA-PLUS Sennosides and Docusate Sodium 8.6 mg; 50 mg Tablet, 100-count — NDC 68788-8780-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

SENNA-PLUS Sennosides and Docusate Sodium 8.6 mg; 50 mg Tablet, 100-count — NDC 68788-8780-1 (Billing 68788-8780-01)

by Preferred Pharmaceuticals Inc. · 100 TABLET in 1 BOTTLE

This is a package of 100 tablets of SENNA-PLUS Sennosides and Docusate Sodium 8.6 mg; 50 mg Tablet from Preferred Pharmaceuticals Inc., marketed since Dec 2024 and currently FDA-listed. It is the main listing for this product, which comes in 3 package sizes.

NDC 68788-8780-01
🏷️ FDA NDC (as labeled) 68788-8780-1 billing pads the package segment with a zero
This package
Contains100-count Pack sizes3 compare ↓
Main listing for product 68788-8780 · Also comes in: 30 tablets 68788-8780-3 120 tablets 68788-8780-8
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Aug 27, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 68788-8780-1 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
68788 labeler · 8780 product · 1 package
Package marketed since
Dec 11, 2024
Sample package
No — commercial package
Listing certified through
Dec 31, 2027
Billing quantity
100 EA per package
Barcode (UPC-A, from the NDC)
3 6878887801 4
FDA record last changed
Aug 27, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 68788-8780-1
Product NDC 68788-8780
11-digit billing NDC 68788878001
NCPDP billing unit EA — each (per item)
RxCUI 998740
UNII 3FYP5M0IJX, F05Q2T2JA0
Application # 505G(a)(3)
SPL Set ID d7146449-c43e-460a-9ae0-aa1966eaa3b6
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2024-12-11
Route ORAL
Dosage form TABLET
Substance SENNOSIDES; DOCUSATE SODIUM
Quick answers
  • RxCUI (RxNorm): 998740
Why two NDCs? The FDA registers this code as 68788-8780-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 68788-8780-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Contact laxatives class.

Drug family (ATC) Contact laxatives
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📖 About the active ingredient: Sennosides; Docusate Sodium MedlinePlus · NLM
General information about the ingredient itself — the description of this specific product follows below.

Senna is used on a short-term basis to treat constipation. It also is used to empty the bowels before surgery and certain medical procedures. Senna is in a class of medications called stimulant laxatives. It works by increasing activity of the intestines to cause a bowel movement.

Read the full MedlinePlus article ↗
🧪 What is this product?

Senna-Plus is an over-the-counter oral tablet containing two active ingredients that work together to support bowel regularity. Sennosides, a natural laxative derived from senna plant material, are typically used to stimulate intestinal contractions and promote bowel movements. Docusate sodium is a stool softener commonly included to help ease passage by increasing water content in the stool. This combination product is marketed as an OTC monograph drug, meaning it follows FDA's established safety and use guidelines for this category.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 30 tablets 120 tablets
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
68788-8780-01 You're viewing this Main listing 100 TABLET in 1 BOTTLE 2024-12-11 — Active
68788-8780-03 68788-8780-3 30 TABLET in 1 BOTTLE 2024-12-11 — Active
68788-8780-08 68788-8780-8 120 TABLET in 1 BOTTLE 2024-12-11 — Active

You're viewing one of 3 pack sizes for this product.

Pack size FAQ

What quantity is in this package?
This is a 100-count package — 100 tablet in 1 bottle.
How does this package differ from NDC 68788-8780-03?
Both are SENNA-PLUS Sennosides and Docusate Sodium 8.6 mg; 50 mg Tablet — the drug itself is identical. This page's package is the 100-count one, while NDC 68788-8780-03 is the 30 tablets package.
What NDC number is used to bill for this package of SENNA-PLUS Sennosides and Docusate Sodium 8.6 mg; 50 mg Tablet?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Senexon-S 8.6 mg/1; 50 mg 00536-1247-01 RUGBY 100 tablets $0.030 — Availability likely —
Stimulant Laxative Plus Stool Softener 8.6 mg/1; 50 mg 00536-1248-01 RUGBY 100 tablets $0.030 — Availability likely —
Sennosides, Docusate Sodium 50 mg/1; 8.6 mg 00904-7440-61 Major 10 tablets $0.030 — Availability likely —
Senna Plus 50 mg/1; 8.6 mg 46122-0625-72 AmerisourceBergen 60 tablets $0.030 — Availability likely —
Stool Softener Laxative 50 mg/1; 8.6 mg 46122-0669-78 AmerisourceBergen 100 tablets $0.030 — Availability likely —
Sennosides and Docusate Sodium 8.6 mg/1; 50 mg 60687-0622-01 American 100 tablets $0.030 — Availability likely —
Senna Plus 8.6 mg/1; 50 mg 70000-0520-01 CARDINAL 30 tablets $0.030 — Availability likely —
Stool Softener plus Stimulant Laxative 8.6 mg/1; 50 mg 70000-0526-01 CARDINAL 100 tablets $0.030 — Availability likely —
Senna-S 8.6 mg/1; 50 mg 70677-1069-01 STRATEGIC 60 tablets $0.030 — Availability likely —
Stool Softener 50 mg/1; 8.6 mg 70677-1094-01 Strategic 100 tablets $0.030 — Availability likely —
Senna S 50 mg/1; 8.6 mg 83324-0135-60 QUALITY 60 tablets $0.030 — Availability likely —
Stool Softener 50 mg/1; 8.6 mg 83324-0136-01 QUALITY 100 tablets $0.030 — Availability likely —
Senna-S 50 mg/1; 8.6 mg 70677-1246-01 Strategic 100 tablets $0.032 — FDA listed —
Colace 50 mg/1; 8.6 mg 67618-0110-10 Atlantis 5 tablets $0.412 — Availability likely —
Senokot-S 8.6 mg/1; 50 mg 67618-0310-01 Atlantis 10 tablets $0.412 — Availability likely —
Stool Softener Laxative Plus Stimulant 50 mg/1; 8.6 mg 00363-0827-20 Walgreens 200 tablets — — FDA listed —
Senna S 50 mg/1; 8.6 mg 00363-0883-12 Walgreens 120 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 00363-8550-20 Walgreens 200 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 00363-8780-20 Walgreens 200 tablets — — Discontinued —
Senexon-S 8.6 mg/1; 50 mg 00615-8331-39 NCS 30 tablets — — FDA listed —
Senna-S Laxative With Stool Softener 50 mg/1; 8.6 mg 00761-0910-02 Basic 100 tablets — — FDA listed —
Senna S 8.6 mg/1; 50 mg 10135-0669-01 Marlex 100 tablets — — FDA listed —
Stool Softening Senna Laxative 50 mg/1; 8.6 mg 11673-0192-03 TARGET 30 tablets — — FDA listed —
Stool Softener And Stimulant Laxative 8.6 mg/1; 50 mg 11673-0209-01 TARGET 100 tablets — — FDA listed —
Senna-S 8.6 mg/1; 50 mg 16103-0378-07 Pharbest 60 tablets — — FDA listed —
Stimulant Laxative Plus Stool Softener 8.6 mg/1; 50 mg 17856-1248-01 ATLANTIC 1 tablet — — FDA listed —
Natural Vegetable Laxative and Stool Softener 50 mg/1; 8.6 mg 21130-0219-03 BETTER 30 tablets — — FDA listed —
Stool Softener Plus Stimulant Laxative 50 mg/1; 8.6 mg 21130-0829-20 Safeway, 200 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 21130-0855-20 Safeway, 200 tablets — — FDA listed —
Stool Softener Plus Stimulant Laxative 50 mg/1; 8.6 mg 21130-0878-20 Safeway, 200 tablets — — FDA listed —
Senna S 50 mg/1; 8.6 mg 21130-0883-30 Safeway, 30 tablets — — FDA listed —
Stool Softener 8.6 mg/1; 50 mg 21130-0902-20 BETTER 200 tablets — — FDA listed —
Stool Softener Plus Stimulant Laxative 50 mg/1; 8.6 mg 36800-0084-01 TOP 100 tablets — — FDA listed —
Senna S 50 mg/1; 8.6 mg 36800-0783-12 TOP 120 tablets — — FDA listed —
Laxative Docusate Sodium with Senna 50 mg/1; 8.6 mg 36800-0861-01 TOPCO 100 tablets — — FDA listed —
Vegetable Laxative and Stool Softner 50 mg/1; 8.6 mg 36800-0938-60 TOPCO 60 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 37808-0355-12 H 120 tablets — — FDA listed —
Stool Softener and Stimulant Laxative 50 mg/1; 8.6 mg 37808-0549-29 H-E-B 240 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 37808-0878-12 H 120 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 41163-0755-10 United 100 tablets — — FDA listed —
Stool Softener Plus Stimulant 50 mg/1; 8.6 mg 41163-0778-10 United 100 tablets — — FDA listed —
Stool Softener Plus Stimulant Laxative 50 mg/1; 8.6 mg 41163-0829-10 United 100 tablets — — FDA listed —
Senna S 50 mg/1; 8.6 mg 41163-0883-30 United 30 tablets — — FDA listed —
Senna-S 8.6 mg/1; 50 mg 41226-0192-06 KROGER 60 tablets — — FDA listed —
Stool Softener-Stimulant Laxative 8.6 mg/1; 50 mg 41226-0209-06 Kroger 60 tablets — — FDA listed —
Sool Softener Laxative 50 mg/1; 8.6 mg 49035-0270-30 EQUATE 30 tablets — — FDA listed —
Laxative and Stool Softener 50 mg/1; 8.6 mg 49035-0360-30 EQUATE 30 tablets — — FDA listed —
Senna Time S 50 mg/1; 8.6 min 49483-0081-00 TIME 100000 tablets — — FDA listed —
Sennosides And Docusate Sodium 8.6 mg/1; 50 mg 49483-0097-00 TIME 100000 tablets — — FDA listed —
Laxacin 50 mg/1; 8.6 mg 50488-0901-01 Alexso, 100 tablets — — FDA listed —
Stimulant Laxative Plus Stool Softener 8.6 mg/1; 50 mg 50804-0304-10 GOOD 100 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 50804-0855-10 Good 100 tablets — — Discontinued —
Senna S 50 mg/1; 8.6 mg 53329-0989-62 Medline 60 tablets — — FDA listed —
Drug Mart Vegetable Laxative plus Stool Softener 50 mg/1; 8.6 mg 53943-0153-01 Discount 100 tablets — — FDA listed —
Drug Mart Stool Softener plus Stimulant Laxative 50 mg/1; 8.6 mg 53943-0154-01 Discount 100 tablets — — FDA listed —
Senna S 50 mg/1; 8.6 mg 54257-0089-02 Magno-Humphries, 100 tablets — — FDA listed —
Sennosides, Docusate Sodium 50 mg/1; 8.6 mg 55154-0195-00 Cardinal 10 tablets — — FDA listed —
Sennosides and Docusate Sodium 8.6 mg/1; 50 mg 55154-2578-00 Cardinal 10 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 55319-0565-10 Family 100 tablets — — FDA listed —
Stool Softener Laxative Plus Stimulant 50 mg/1; 8.6 mg 55910-0829-10 Dolgencorp, 100 tablets — — FDA listed —
Stool Softener Laxative Plus Stimulant 50 mg/1; 8.6 mg 55910-0855-10 Dolgencorp, 100 tablets — — FDA listed —
Stool Softener Laxative Plus Stimulant 50 mg/1; 8.6 mg 55910-0978-10 Dolgencorp, 100 tablets — — FDA listed —
Stool Softener with Laxative 8.6 mg/1; 50 mg 57896-0304-01 Geri-Care 100 tablets — — FDA listed —
Senna Plus 8.6 mg/1; 50 mg 57896-0458-10 Geri-Care 1000 tablets — — FDA listed —
Senna-Plus 8.6 mg/1; 50 mg 57896-0555-01 Geri-Care 100 tablets — — FDA listed —
Stool Softener with Stimulant Laxative 50 mg/1; 8.6 mg 59726-0855-10 P 100 tablets — — FDA listed —
Stool Softener with Stimulant Laxative 50 mg/1; 8.6 mg 59726-0878-10 P 100 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 62011-0417-01 Strategic 100 tablets — — Discontinued —
Docusate Sodium and Sennosides 50 mg/1; 8.6 mg 62993-0002-01 Morepen 30 tablets — — FDA listed —
Senna-S 8.6 mg/1; 50 mg 63561-0187-01 Granulation 100 tablets — — FDA listed —
Stool Softener Stimulant laxative 50 mg/1; 8.6 mg 63868-0875-01 QUALITY 100 tablets — — FDA listed —
Stool Softener plus Laxative 50 mg/1; 8.6 mg 63868-0878-60 QUALITY 60 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 63868-0884-01 QUALITY 100 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 63868-0946-01 QUALITY 100 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 63941-0855-10 Best 100 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 63941-0878-10 Best 100 tablets — — FDA listed —
Stool Softener with laxative 50 mg/1; 8.6 mg 67091-0328-60 WinCo 60 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 67091-0373-60 WinCo 60 tablets — — FDA listed —
Stimulant Laxative Plus Stool Softener 8.6 mg/1; 50 mg 68788-7674-01 Preferred 100 tablets — — FDA listed —
Senna-Plus 8.6 mg/1; 50 mgthis 68788-8780-01 Preferred 100 tablets — — FDA listed —
Senna-S 8.6 mg/1; 50 mg 69517-0131-02 HealthLife 2 tablets — — FDA listed —
Sennosides and Docusate Sodium 8.6 mg/1; 50 mg 69618-0065-01 Reliable-1 100 tablets — — FDA listed —
Colon Detox 50 mg/1; 8.6 mg 69729-0151-60 OPMX 60 tablets — — FDA listed —
Laxative Stool Softener 50 mg/1; 8.6 mg 69842-0776-18 CVS 180 tablets — — FDA listed —
Stool Softener Plus Stimulant Laxative 50 mg/1; 8.6 mg 69842-0881-10 CVS 100 tablets — — FDA listed —
Senna Plus 50 mg/1; 8.6 mg 69842-0883-18 CVS 180 tablets — — FDA listed —
Stool Softener Plus Stimulant Laxative 50 mg/1; 8.6 mg 69842-0887-10 CVS 100 tablets — — FDA listed —
Docuzen 8.6 mg/1; 50 mg 71205-0282-30 Proficient 30 tablets — — FDA listed —
Senna-S 8.6 mg/1; 50 mg 71205-0970-00 Proficient 100 tablets — — FDA listed —
Senna-Plus 8.6 mg/1; 50 mg 71335-1674-01 Bryant 30 tablets — — FDA listed —
Stool Softener with Laxative 8.6 mg/1; 50 mg 71335-2522-01 Bryant 30 tablets — — FDA listed —
Stimulant Laxative Plus Stool Softener 8.6 mg/1; 50 mg 71335-2693-01 Bryant 30 tablets — — FDA listed —
Docuzen 8.6 mg/1; 50 mg 71574-0700-60 Village 60 tablets — — FDA listed —
Senna-S 50 mg/1; 8.6 mg 72090-0030-20 Pioneer 200 tablets — — FDA listed —
Stool Softener Plus Stimulant Laxative 50 mg/1; 8.6 mg 72476-0855-10 Care 100 tablets — — FDA listed —
Stool Softener Plus Stimulant Laxative 50 mg/1; 8.6 mg 72476-0878-10 Care 100 tablets — — FDA listed —
Senna S Orange 50 mg/1; 8.6 mg 72476-0883-60 Care 60 tablets — — FDA listed —
Senna-S 8.6 mg/1; 50 mg 73057-0378-07 Ulai 60 tablets — — FDA listed —
Sennosides and Docusate Sodium 8.6 mg/1; 50 mg 76420-0918-01 Asclemed 100 tablets — — FDA listed —
Stool Softener plus Stimulant Laxative 8.6 mg/1; 50 mg 79481-0304-01 Meijer, 100 tablets — — FDA listed —
Senna-S 8.6 mg/1; 50 mg 79481-0555-06 Meijer, 60 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 79903-0009-12 WALMART 120 tablets — — FDA listed —
Senna-Plus 50 mg/1; 8.6 mg 80136-0555-01 Heartland 100 tablets — — Discontinued —
Laxacin 50 mg/1; 8.6 mg 80425-0345-01 Advanced 100 tablets — — FDA listed —
Senna-S 8.6 mg/1; 50 mg 80513-0105-25 Advanced 250 tablets — — FDA listed —
Senna With Docusate Sodium 8.6 mg/1; 50 mg 83586-0001-00 HHH 50000 tablets — — FDA listed —
Senna-S 50 mg/1; 8.6 mg 84324-0013-01 NUVICARE 100 tablets — — FDA listed —
Senna-S 8.6 mg/1; 50 mg 85111-0455-10 RMT 1000 tablets — — FDA listed —
Healix Senna-S 8.6 mg/1; 50 mg 87275-2451-01 Brainstorm 100 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2024
On the market since
Dec 2024
📍
2026
Currently FDA-listed
2 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII L11K75P92J
    A mineral salt made from calcium and phosphate. It acts as a filler and binder in tablets to add bulk and help hold the medicine together in solid form.
  • UNII M28OL1HH48
    Croscarmellose sodium is a plant-based substance derived from cellulose. It acts as a disintegrant, helping tablets and capsules break down quickly in the digestive system so the medicine can be absorbed.
  • UNII H77VEI93A8
    A synthetic yellow dye used to color medications. It helps identify the drug and make it visually distinctive, with no effect on how the medicine works.
  • UNII 3NXW29V3WO
    Hypromellose is a plant-based thickener made from cellulose. It's used in medicines as a binder to hold ingredients together, a coating for tablets, and a thickener for liquids.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
  • UNII 3WJQ0SDW1A
    Polyethylene glycol is a synthetic liquid or solid polymer used in medicines as a solvent, lubricant, and humectant. It helps dissolve active ingredients, reduces friction during manufacturing, and retains moisture in the final product.
  • UNII ETJ7Z6XBU4
    Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
  • UNII 7SEV7J4R1U
    A powder made from a naturally occurring mineral. In medicines, talc works as a glidant and anti-caking agent, helping tablets and capsules flow smoothly during manufacturing and preventing clumping.
  • UNII 15FIX9V2JP
    Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.

10 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statescellulose, croscarmellose sodium, dicalcium phosphate, FD&C yellow #6 lake, hypromellose, magnesium stearate, PEG, silica, talc, titanium dioxide.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerPreferred Pharmaceuticals Inc.
FDA application505G(a)(3) (OTC MONOGRAPH DRUG)
Labeler code68788
First marketedDec 2024
Product typeHuman Otc Drug
Portfolio833 products on file

More NDCs from Preferred Pharmaceuticals Inc. labeler code 68788

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 19 words ▾

Uses • relieves occasional constipation (irregularity) • this product generally produces a bowel movement in 6 to 12 hours

⏱️ Dosage and Administration 58 words ▾

Directions • do not exceed 8 tablets in 24 hours Age Starting Dose Maximum Dose adults and children 12 years of age and older 2 tablets once a day preferably at bedtime; increase as needed, or as directed by a doctor 4 tablets in the morning and 4 tablets at bedtime children under 12 years ask a doctor

⚠️ Warnings 107 words ▾

Warnings Do not use for more than one week unless directed by a doctor Ask a doctor before use if you • have abdominal pain, nausea or vomiting • are taking mineral oil • have noticed a sudden change in bowel habits that lasts over two weeks Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition. If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

📦 Storage and Handling 41 words ▾

Other information • each tablet contains: calcium 20 mg, sodium 3 mg • store at controlled room temperature Tamper Evident: Do not use if imprinted seal under cap is missing or broken. • product of India Repackaged By: Preferred Pharmaceuticals Inc.

🧪 Active Ingredient 12 words ▾

Active ingredient (in each tablet) Docusate Sodium 50 mg Sennosides 8.6 mg

🧪 Inactive Ingredients 19 words ▾

Inactive ingredients cellulose, croscarmellose sodium, dicalcium phosphate, FD&C yellow #6 lake, hypromellose, magnesium stearate, PEG, silica, talc, titanium dioxide.

🎯 Purpose 4 words ▾

Purpose Stool softener Laxative

📄 Keep Out of Reach of Children 21 words ▾

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

📄 Package Label / Principal Display Panel 5 words ▾

Package Label Senna Plus Tablets

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for SENNA-PLUS (this brand).

Top reported reactions

Constipation3
Atrial Fibrillation2
Diarrhoea2
Neuropathy Peripheral2
Oedema Peripheral2
Rash2
White Blood Cell Count Decreased2

Age at onset

Adult1
Elderly5

Reporter sex

19 reports
Male · 47%
Female · 53%

Serious outcomes

Hospitalization6
Reports over time (by year) — tap or hover for the count & year
2020 2022 2024 2026 4 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Preferred Pharmaceuticals Inc.. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 2 other package presentations of this same product, including 30 tablets (68788-8780-03), 120 tablets (68788-8780-08). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Preferred Pharmaceuticals Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 68788-8779-03 · Preferred 68788-8782-03 · Preferred →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.